Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
02 May 2023
// FDA
21 Nov 2022
// EMA
30 Sep 2022
// EMA
25 Mar 2022
// F. Kansteiner FIERCEPHARMA
11 May 2021
// BIOSPACE
31 Mar 2021
// FDA
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory FDF Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
10 Aug 2024
Reply
22 May 2024
Reply
15 Mar 2024
Reply
04 Jul 2023
Reply
21 Jul 2022
Reply
15 Jul 2022
Reply
27 May 2022
Reply
02 May 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
48
PharmaCompass offers a list of Ertapenem API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ertapenem manufacturer or Ertapenem supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ertapenem manufacturer or Ertapenem supplier.
PharmaCompass also assists you with knowing the Ertapenem API Price utilized in the formulation of products. Ertapenem API Price is not always fixed or binding as the Ertapenem Price is obtained through a variety of data sources. The Ertapenem Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Invanz manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Invanz, including repackagers and relabelers. The FDA regulates Invanz manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Invanz API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Invanz manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Invanz supplier is an individual or a company that provides Invanz active pharmaceutical ingredient (API) or Invanz finished formulations upon request. The Invanz suppliers may include Invanz API manufacturers, exporters, distributors and traders.
click here to find a list of Invanz suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Invanz DMF (Drug Master File) is a document detailing the whole manufacturing process of Invanz active pharmaceutical ingredient (API) in detail. Different forms of Invanz DMFs exist exist since differing nations have different regulations, such as Invanz USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Invanz DMF submitted to regulatory agencies in the US is known as a USDMF. Invanz USDMF includes data on Invanz's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Invanz USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Invanz suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Invanz Drug Master File in Korea (Invanz KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Invanz. The MFDS reviews the Invanz KDMF as part of the drug registration process and uses the information provided in the Invanz KDMF to evaluate the safety and efficacy of the drug.
After submitting a Invanz KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Invanz API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Invanz suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Invanz as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Invanz API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Invanz as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Invanz and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Invanz NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Invanz suppliers with NDC on PharmaCompass.
Invanz Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Invanz GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Invanz GMP manufacturer or Invanz GMP API supplier for your needs.
A Invanz CoA (Certificate of Analysis) is a formal document that attests to Invanz's compliance with Invanz specifications and serves as a tool for batch-level quality control.
Invanz CoA mostly includes findings from lab analyses of a specific batch. For each Invanz CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Invanz may be tested according to a variety of international standards, such as European Pharmacopoeia (Invanz EP), Invanz JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Invanz USP).
Share 
Comment (4)
